Paralyzed stomachs, gallbladder removal and more: Lawsuits pile up against makers of diabetes, weight loss drugs Ozempic, Wegovy

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. AP Photo/David J. Phillip, File

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File)

A series of hefty lawsuits are barreling ahead throughout the United States from a wide array of people who claim Novo Nordisk and Eli Lily, makers of diabetes and weight loss drugs like Ozempic, Wegovy and others, failed to warn them about potentially dangerous side effects and risks including stomach paralysis and damage to the gallbladder so severe it would require removal in some instances.

So numerous are these and similar allegations coming in from users of the injectable drugs known as “GLP-1 agonists” in states like Arizona, Illinois, North Carolina, Texas and elsewhere, that a multidistrict litigation proceeding before a federal judge in the Pennsylvania only last week opted to centralize the cases as they proceed.

You May Also Like

NIH Funding Cuts Will Hit Red States and the Poor Hardest

The National Institutes of Health is the largest federal funder of medical…